Clinical Trial Update: Observation of the Use of QUTENZA™ in Standard Clinical Practice

View source ↗

Summary

Observational update on the real-world use of QUTENZA (capsaicin 8% patch) in standard clinical practice for peripheral neuropathic pain; the trial has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Neuropathic Pain

Drugs mentioned

• QUTENZA (Capsaicin)

Snippet

Sponsor: Astellas Pharma Europe Ltd. | Conditions: Peripheral Neuropathic Pain | Status: COMPLETED